Peter Connick

2.6k total citations · 1 hit paper
33 papers, 972 citations indexed

About

Peter Connick is a scholar working on Pathology and Forensic Medicine, Physiology and Neurology. According to data from OpenAlex, Peter Connick has authored 33 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 6 papers in Physiology and 5 papers in Neurology. Recurrent topics in Peter Connick's work include Multiple Sclerosis Research Studies (22 papers), Alzheimer's disease research and treatments (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Peter Connick is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Alzheimer's disease research and treatments (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Peter Connick collaborates with scholars based in United Kingdom, United States and Italy. Peter Connick's co-authors include Siddharthan Chandran, Rickie Patani, Alan J. Thompson, Daniel R. Altmann, Alastair Compston, Michael A. Scott, Ming‐Qing Du, Andrew W. Michell, Madhan Kolappan and David H. Miller and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Peter Connick

31 papers receiving 947 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

2012 457 citations Peter Connick, Madhan Kolappan et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Connick United Kingdom	15	351	306	253	171	145	33	972
Laureen D. Hachem Canada	16	257 0.7×	328 1.1×	199 0.8×	67 0.4×	112 0.8×	35	964
Aline Herlopian United States	13	235 0.7×	157 0.5×	138 0.5×	86 0.5×	175 1.2×	30	1.1k
Mohammed Al Jumah Saudi Arabia	22	638 1.8×	389 1.3×	303 1.2×	42 0.2×	111 0.8×	58	1.8k
Sabine Schädelin Switzerland	14	84 0.2×	452 1.5×	353 1.4×	89 0.5×	349 2.4×	40	1.4k
Laura Otero‐Ortega Spain	23	512 1.5×	118 0.4×	728 2.9×	248 1.5×	227 1.6×	56	1.6k
Mariangela Farinotti Italy	19	335 1.0×	463 1.5×	108 0.4×	29 0.2×	189 1.3×	44	1.3k
Yujia Yang China	16	124 0.4×	84 0.3×	164 0.6×	106 0.6×	104 0.7×	59	691
John S. Romine United States	16	141 0.4×	421 1.4×	163 0.6×	71 0.4×	183 1.3×	26	1.0k
Astrid Blaschek Germany	24	348 1.0×	762 2.5×	388 1.5×	34 0.2×	598 4.1×	74	1.7k
Ulrich W. Thomale Germany	16	215 0.6×	154 0.5×	175 0.7×	44 0.3×	368 2.5×	41	928

Countries citing papers authored by Peter Connick

Since Specialization

Citations

This map shows the geographic impact of Peter Connick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Connick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Connick more than expected).

Fields of papers citing papers by Peter Connick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Connick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Connick. The network helps show where Peter Connick may publish in the future.

Co-authorship network of co-authors of Peter Connick

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Connick. A scholar is included among the top collaborators of Peter Connick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Connick. Peter Connick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meijboom, Rozanna, Peter Foley, Niall MacDougall, et al.. (2024). Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration. Brain Communications. 6(5). fcae278–fcae278.

Meijboom, Rozanna, Agniete Kampaite, Mathew A. Harris, et al.. (2023). Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis. PLoS ONE. 18(7). e0288967–e0288967. 6 indexed citations

Brown, J William L, Ferrán Prados, Daniel R. Altmann, et al.. (2022). Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Annals of Clinical and Translational Neurology. 9(10). 1626–1642. 14 indexed citations

Glasmacher, Stella A., Patrick K. A. Kearns, Peter Connick, et al.. (2022). The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 63. 103837–103837. 8 indexed citations

Foley, Peter, Richard Parker, Floriana De Angelis, et al.. (2022). Efficacy of Fluoxetine, Riluzole and Amiloride in treating neuropathic pain associated with secondary progressive multiple sclerosis. Pre-specified analysis of the MS-SMART double-blind randomised placebo-controlled trial. Multiple Sclerosis and Related Disorders. 63. 103925–103925. 6 indexed citations

Kearns, Patrick K. A., Alan Carson, David Gillespie, et al.. (2022). Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 69. 104429–104429. 9 indexed citations

Glasmacher, Stella A., Patrick K. A. Kearns, Niall MacDougall, et al.. (2020). Systematic review of prediction models in relapsing remitting multiple sclerosis. PLoS ONE. 15(5). e0233575–e0233575. 27 indexed citations

Patrick, Sarah & Peter Connick. (2019). Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review. PLoS ONE. 14(2). e0197943–e0197943. 47 indexed citations

Torvell, Megan, David W. Hampton, Peter Connick, et al.. (2019). A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 579–591. 12 indexed citations

10.

Kearns, Patrick K. A., Martin Paton, Shuna Colville, et al.. (2019). Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010–2017: findings from the Scottish Multiple Sclerosis Register. Journal of Neurology. 266(10). 2376–2386. 17 indexed citations

11.

Marshall, Ian, Michael J. Thrippleton, Mark E. Bastin, et al.. (2018). Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study. Journal of Neurology. 265(8). 1795–1802. 6 indexed citations

12.

Mollison, Daisy, Robin Sellar, Mark E. Bastin, et al.. (2017). The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis. PLoS ONE. 12(5). e0177727–e0177727. 52 indexed citations

13.

Chataway, Jeremy, Siddharthan Chandran, David S. Miller, et al.. (2016). THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MS – CURRENT UPDATE. Journal of Neurology Neurosurgery & Psychiatry. 87(12). e1.61–e1. 3 indexed citations

14.

Leighton, Danielle, Elaine Cleary, Laura Stephenson, et al.. (2016). Genetic epidemiology of motor neuron disease-associated variants in the Scottish population. Neurobiology of Aging. 51. 178.e11–178.e20. 33 indexed citations

15.

Rzechorzek, Nina M., Peter Connick, Matthew R. Livesey, et al.. (2015). Hypothermic Preconditioning Reverses Tau Ontogenesis in Human Cortical Neurons and is Mimicked by Protein Phosphatase 2A Inhibition. EBioMedicine. 3. 141–154. 8 indexed citations

16.

Rzechorzek, Nina M., Peter Connick, Rickie Patani, Bhuvaneish T. Selvaraj, & Siddharthan Chandran. (2015). Hypothermic Preconditioning of Human Cortical Neurons Requires Proteostatic Priming. EBioMedicine. 2(6). 528–535. 35 indexed citations

17.

Vesterinen, H. M., Peter Connick, Cadi Irvine, et al.. (2015). Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis. PLoS ONE. 10(4). e0117705–e0117705. 46 indexed citations

18.

Connick, Peter, Madhan Kolappan, Charles Crawley, et al.. (2012). Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. The Lancet Neurology. 11(2). 150–156. 457 indexed citations breakdown →

19.

Connick, Peter, Rickie Patani, & Siddharthan Chandran. (2011). Stem cells as a resource for regenerative neurology. Practical Neurology. 11(1). 29–36. 5 indexed citations

20.

Connick, Peter, et al.. (2009). Procedural confidence in hospital based practitioners: implications for the training and practice of doctors at all grades. BMC Medical Education. 9(1). 2–2. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact